Poor implementation of the EU clinical trial regulation is a major threat for pragmatic trials in European countries
Ostuzzi, Giovanni and Gastaldon, Chiara and Petrini, Carlo and Godman, Brian and Barbui, Corrado (2020) Poor implementation of the EU clinical trial regulation is a major threat for pragmatic trials in European countries. Epidemiology and Psychiatric Sciences, 29 (6). e126. ISSN 2045-7960
|
Text (Ostuzzi-etal-EPS-2020-Poor-implementation-of-the-eu-clinical-trial-regulation)
Ostuzzi_etal_EPS_2020_Poor_implementation_of_the_eu_clinical_trial_regulation.pdf Final Published Version License: ![]() Download (155kB)| Preview |
Official URL: https://doi.org/10.1017/S2045796020000396
Abstract
The principle of pragmatism in clinical trials has been broadly recognised as a way to close the gap between research and practice. In this contribution, we argue that the conduct of pragmatic clinical trials in Europe may be hampered by poor implementation of current European Union's Clinical Trial Regulation No. 536/2014.
Creators(s): | Ostuzzi, Giovanni, Gastaldon, Chiara, Petrini, Carlo, Godman, Brian and Barbui, Corrado; | Item type: | Article |
---|---|
ID code: | 72330 |
Keywords: | Italian medicine agency, clinical trials, clinical trial regulations, Pharmacy and materia medica, Pharmacology, Toxicology and Pharmaceutics(all) |
Subjects: | Medicine > Pharmacy and materia medica |
Department: | Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences |
Depositing user: | Pure Administrator |
Date deposited: | 07 May 2020 15:49 |
Last modified: | 21 Jan 2021 11:56 |
URI: | https://strathprints.strath.ac.uk/id/eprint/72330 |
Export data: |
CORE (COnnecting REpositories)